Is the release of brain natriuretic peptide a predictor of improved left-ventricular function in patients with heart failure and cardiac resynchronization therapy?

被引：0
|
作者：
Sinha, AM
Breithardt, OA
Filzmaier, K
Markus, KU
Graf, J
Kunz, D
Hanrath, P
Stellbrink, C
机构：
[1] Univ Hosp Aachen, Med Clin 1, Aachen, Germany
[2] Univ Hosp Aachen, Inst Clin Chem, Aachen, Germany
来源：
EUROPEAN HEART JOURNAL | 2003年 / 24卷
关键词：
D O I：
10.1016/S0195-668X(03)93754-7
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [21] Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure
    Qiong Qiu
    Yang-xin Chen
    Jing-ting Mai
    Wo-liang Yuan
    Yu-lin Wei
    Ying-mei Liu
    Li Yang
    Jing-feng Wang
    The International Journal of Cardiovascular Imaging, 2015, 31 : 329 - 337
  • [22] Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunction
    Hai, Ofek Y.
    Mentz, Robert J.
    Zannad, Faiez
    Gasparini, Maurizio
    De Ferrari, Gaetano M.
    Daubert, Jean-Claude
    Holzmeister, Johannes
    Lam, Carolyn S. P.
    Pochet, Thierry
    Vincent, Alphons
    Linde, Cecilia
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (02) : 135 - 143
  • [23] Effects of cardiac resynchronization therapy on left ventricular remodeling and dyssynchrony in patients with left ventricular noncompaction and heart failure
    Qiu, Qiong
    Chen, Yang-xin
    Mai, Jing-ting
    Yuan, Wo-liang
    Wei, Yu-lin
    Liu, Ying-mei
    Yang, Li
    Wang, Jing-feng
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2015, 31 (02): : 329 - 337
  • [24] What proportion of patients with heart failure and preserved left-ventricular systolic dysfunction has an elevated brain natriuretic peptide?
    Hogg, K
    McMurray, JJV
    Morton, JJ
    Lundmark, E
    Rooney, E
    Christie, J
    Kay, D
    Newman, E
    EUROPEAN HEART JOURNAL, 2003, 24 : 255 - 255
  • [25] Brain natriuretic peptide, but not norepinephrine, predicts improvements in left-ventricular structure and function in patients with chronic heart failure enrolled to Val-HeFT
    Latini, R
    Wong, M
    Masson, S
    Staszewsky, L
    Maggioni, AP
    Anand, IS
    Cohn, JN
    EUROPEAN HEART JOURNAL, 2003, 24 : 34 - 34
  • [26] Correlation of brain natriuretic peptide release, cardiopulmonary exercise testing, and six-minute walking test in patients with heart failure and cardiac resynchronization therapy
    Sinha, AM
    Filzmaier, K
    Kunz, D
    Markus, KU
    Graf, J
    Breithardt, OA
    Hanrath, P
    Stellbrink, C
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 216A - 216A
  • [27] Brain natriuretic peptide and N terminal pro-brain natriuretic peptide for treatment monitoring in patients with left-ventricular systolic heart failure: a substudy of the CARMEN trial
    Groenning, BA
    Hildebrandt, P
    Riegger, GA
    Nilsson, JC
    Komajda, M
    Ryden, L
    Remme, WJ
    EUROPEAN HEART JOURNAL, 2003, 24 : 361 - 361
  • [28] Echocardiographic screening for heart failure must analyse left-ventricular longitudinal function. Comparison versus brain natriuretic peptide
    Vinereanu, D
    Lim, P
    Nicolaides, E
    Frenneaux, M
    Cinteza, M
    Fraser, AG
    EUROPEAN HEART JOURNAL, 2003, 24 : 351 - 351
  • [29] CARDIAC EFFECTS OF ATRIAL NATRIURETIC PEPTIDE IN SUBJECTS WITH NORMAL LEFT-VENTRICULAR FUNCTION
    INDOLFI, C
    PISCIONE, F
    VOLPE, M
    FOCACCIO, A
    LEMBO, G
    TRIMARCO, B
    CONDORELLI, M
    CHIARIELLO, M
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (05): : 353 - 357
  • [30] Longitudinal ventricular function to determine the effect of cardiac resynchronization therapy in patients with heart failure
    Oestenson, B.
    Ostenfeld, E.
    Bakos, Z.
    Kanski, M.
    Heiberg, E.
    Arheden, H.
    Borgquist, R.
    Carlsson, M.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 : 110 - 111
12345